Mario Gabelli Zoetis Inc. Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Zoetis Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 13,710 shares of ZTS stock, worth $2.43 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

13,710

Previous 14,631 6.29%

Holding current value

$2.43 Million

Previous $2.54 Million 5.6%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $158,946 - $180,958	-921 Reduced 6.29%	13,710 $2.68 Million
Q2 2024 Aug 13, 2024	SELL	$145.54 - $178.83 $3.77 Million - $4.63 Million	-25,905 Reduced 63.91%	14,631 $2.54 Million
Q1 2024 May 14, 2024	SELL	$165.67 - $199.94 $471,496 - $569,029	-2,846 Reduced 6.56%	40,536 $6.86 Million
Q3 2023 Nov 08, 2023	SELL	$167.14 - $192.77 $1.9 Million - $2.19 Million	-11,382 Reduced 20.78%	43,382 $7.55 Million
Q2 2023 Aug 10, 2023	BUY	$160.94 - $186.23 $1.05 Million - $1.22 Million	6,547 Added 13.58%	54,764 $9.43 Million
Q1 2023 May 12, 2023	SELL	$145.48 - $175.02 $2.54 Million - $3.05 Million	-17,440 Reduced 26.56%	48,217 $8.03 Million
Q4 2022 Feb 13, 2023	SELL	$131.14 - $157.47 $437,614 - $525,477	-3,337 Reduced 4.84%	65,657 $9.62 Million
Q3 2022 Nov 10, 2022	SELL	$148.29 - $182.55 $385,850 - $474,995	-2,602 Reduced 3.63%	68,994 $10.2 Million
Q2 2022 Aug 12, 2022	SELL	$155.97 - $200.09 $344,693 - $442,198	-2,210 Reduced 2.99%	71,596 $12.3 Million
Q1 2022 May 13, 2022	SELL	$181.39 - $234.03 $617,995 - $797,340	-3,407 Reduced 4.41%	73,806 $13.9 Million
Q4 2021 Feb 11, 2022	SELL	$193.69 - $247.03 $2.8 Million - $3.57 Million	-14,433 Reduced 15.75%	77,213 $18.8 Million
Q3 2021 Nov 12, 2021	SELL	$189.29 - $209.69 $2.54 Million - $2.81 Million	-13,404 Reduced 12.76%	91,646 $17.8 Million
Q2 2021 Aug 13, 2021	SELL	$155.9 - $187.99 $93,695 - $112,981	-601 Reduced 0.57%	105,050 $19.6 Million
Q1 2021 May 14, 2021	SELL	$144.0 - $169.39 $1.18 Million - $1.38 Million	-8,160 Reduced 7.17%	105,651 $16.6 Million
Q4 2020 Feb 05, 2021	SELL	$157.07 - $174.35 $1.73 Million - $1.92 Million	-11,024 Reduced 8.83%	113,811 $18.8 Million
Q3 2020 Nov 06, 2020	SELL	$137.1 - $165.37 $703,048 - $848,017	-5,128 Reduced 3.95%	124,835 $20.6 Million
Q2 2020 Aug 13, 2020	SELL	$111.92 - $142.53 $2.51 Million - $3.19 Million	-22,413 Reduced 14.71%	129,963 $17.8 Million
Q1 2020 May 14, 2020	SELL	$92.66 - $144.94 $686,610 - $1.07 Million	-7,410 Reduced 4.64%	152,376 $17.9 Million
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $2.03 Million - $2.33 Million	-17,455 Reduced 9.85%	159,786 $21.1 Million
Q3 2019 Nov 01, 2019	SELL	$112.57 - $128.43 $1.11 Million - $1.27 Million	-9,859 Reduced 5.27%	177,241 $22.1 Million
Q2 2019 Aug 02, 2019	SELL	$97.98 - $114.28 $1.6 Million - $1.87 Million	-16,320 Reduced 8.02%	187,100 $21.2 Million
Q1 2019 May 02, 2019	SELL	$81.56 - $100.67 $1.25 Million - $1.55 Million	-15,364 Reduced 7.02%	203,420 $20.5 Million
Q4 2018 Jan 30, 2019	SELL	$79.28 - $95.27 $3.51 Million - $4.22 Million	-44,258 Reduced 16.83%	218,784 $18.7 Million
Q3 2018 Nov 02, 2018	SELL	$83.5 - $93.23 $1.15 Million - $1.28 Million	-13,728 Reduced 4.96%	263,042 $24.1 Million
Q2 2018 Aug 10, 2018	SELL	$79.9 - $89.2 $9.34 Million - $10.4 Million	-116,875 Reduced 29.69%	276,770 $23.6 Million
Q1 2018 May 09, 2018	SELL	$71.51 - $84.69 $5.35 Million - $6.33 Million	-74,757 Reduced 15.96%	393,645 $32.9 Million
Q4 2017 Feb 02, 2018	SELL	$63.24 - $72.8 $2.68 Million - $3.08 Million	-42,316 Reduced 8.29%	468,402 $33.7 Million
Q3 2017 Nov 01, 2017	BUY	$59.73 - $65.4 $30.5 Million - $33.4 Million	510,718	510,718 $32.6 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account